| - SMTL ID
- 4bqv.1
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.2
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.3
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.4
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.5
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.6
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.7
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bqv.8
- Ligands
- (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|